Epigenetic alterations of the BDNF gene in combat-related post-traumatic stress disorder

Acta Psychiatrica Scandinavica

Volumn 135, Issue 2, 2017, Pages 170-179

  Kim, T Y ^a   Kim, S J ^b   Chung, H G ^a   Choi, J H ^a   Kim, S H ^c   Kang, J I ^b  

^a Veterans Health Service Medical Center   (South Korea)

^b Yonsei University College of Medicine   (South Korea)

^c Dongguk University Ilsan Hospital   (South Korea)

Author keywords

BDNF; DNA methylation; epigenetics; post traumatic stress disorder; trauma

Indexed keywords

BRAIN DERIVED NEUROTROPHIC FACTOR; DNA; PSYCHOTROPIC AGENT; SEROTONIN UPTAKE INHIBITOR; BRAIN-DERIVED NEUROTROPHIC FACTOR, HUMAN;

ADULT; ARTICLE; BATTLE INJURY; BDNF GENE; CLINICIAN ADMINISTERED POST TRAUMATIC STRESS DISORDER SCALE; CONTROLLED STUDY; CPG ISLAND; DNA METHYLATION; EPIGENETICS; FEMALE; GENE; HUMAN; MAJOR CLINICAL STUDY; MALE; MIDDLE AGED; POSTTRAUMATIC STRESS DISORDER; PRIORITY JOURNAL; PROMOTER REGION; PSYCHOLOGICAL RATING SCALE; PYROSEQUENCING; VETERAN; AGED; COMBAT DISORDERS; GENETIC ASSOCIATION STUDY; GENETIC EPIGENESIS; GENETIC PREDISPOSITION; GENETICS; STATISTICAL MODEL;

AGED; BRAIN-DERIVED NEUROTROPHIC FACTOR; COMBAT DISORDERS; CPG ISLANDS; DNA METHYLATION; EPIGENESIS, GENETIC; GENETIC ASSOCIATION STUDIES; GENETIC PREDISPOSITION TO DISEASE; HUMANS; LOGISTIC MODELS; MALE; MIDDLE AGED; PROMOTER REGIONS, GENETIC; PSYCHIATRIC STATUS RATING SCALES;

EID: 85005847549     PISSN: 0001690X     EISSN: 16000447     Source Type: Journal    
DOI: 10.1111/acps.12675     Document Type: Article

References (54)

1. American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders, 4th edn, text revision. Washington: DC American Psychiatric Association, 2000.
2. Voisey J, Young RM, Lawford BR, Morris CP. Progress towards understanding the genetics of posttraumatic stress disorder. J Anxiety Disord 2014;28:873–883.
3. Zannas AS, Provencal N, Binder EB. Epigenetics of posttraumatic stress disorder: current evidence, challenges, and future directions. Biol Psychiatry 2015;78:327–335.
4. Malan-Muller S, Seedat S, Hemmings SM. Understanding posttraumatic stress disorder: insights from the methylome. Genes Brain Behav 2014;13:52–68.
5. Zovkic IB, Sweatt JD. Epigenetic mechanisms in learned fear: implications for PTSD. Neuropsychopharmacology 2013;38:77–93.
6. Licinio J, Wong M. Brain-derived neurotrophic factor (BDNF) in stress and affective disorders. Mol Psychiatry 2002;7:519.
7. Vollmayr B, Faust H, Lewicka S, Henn FA. Brain-derived-neurotrophic-factor (BDNF) stress response in rats bred for learned helplessness. Mol Psychiatry 2001;6:471–474, 358.
8. Gray JD, Milner TA, McEwen BS. Dynamic plasticity: the role of glucocorticoids, brain-derived neurotrophic factor and other trophic factors. Neuroscience 2013;239:214–227.
9. Park H, Poo MM. Neurotrophin regulation of neural circuit development and function. Nat Rev Neurosci 2013;14:7–23.
10. Chao MV. Neurotrophins and their receptors: a convergence point for many signalling pathways. Nat Rev Neurosci 2003;4:299–309.
11. Roceri M, Hendriks W, Racagni G, Ellenbroek BA, Riva MA. Early maternal deprivation reduces the expression of BDNF and NMDA receptor subunits in rat hippocampus. Mol Psychiatry 2002;7:609–616.
12. Rasmusson AM, Shi L, Duman R. Downregulation of BDNF mRNA in the hippocampal dentate gyrus after re-exposure to cues previously associated with footshock. Neuropsychopharmacology 2002;27:133–142.
13. Heldt SA, Stanek L, Chhatwal JP, Ressler KJ. Hippocampus-specific deletion of BDNF in adult mice impairs spatial memory and extinction of aversive memories. Mol Psychiatry 2007;12:656–670.
14. Soliman F, Glatt CE, Bath KG et al. A genetic variant BDNF polymorphism alters extinction learning in both mouse and human. Science 2010;327:863–866.
15. Korte M, Carroll P, Wolf E, Brem G, Thoenen H, Bonhoeffer T. Hippocampal long-term potentiation is impaired in mice lacking brain-derived neurotrophic factor. Proc Natl Acad Sci USA 1995;92:8856–8860.
16. Liu IY, Lyons WE, Mamounas LA, Thompson RF. Brain-derived neurotrophic factor plays a critical role in contextual fear conditioning. J Neurosci 2004;24:7958–7963.
17. Koponen E, Voikar V, Riekki R et al. Transgenic mice overexpressing the full-length neurotrophin receptor trkB exhibit increased activation of the trkB-PLCgamma pathway, reduced anxiety, and facilitated learning. Mol Cell Neurosci 2004;26:166–181.
18. Takei S, Morinobu S, Yamamoto S, Fuchikami M, Matsumoto T, Yamawaki S. Enhanced hippocampal BDNF/TrkB signaling in response to fear conditioning in an animal model of posttraumatic stress disorder. J Psychiatr Res 2011;45:460–468.
19. Roth TL, Zoladz PR, Sweatt JD, Diamond DM. Epigenetic modification of hippocampal Bdnf DNA in adult rats in an animal model of post-traumatic stress disorder. J Psychiatr Res 2011;45:919–926.
20. Lubin FD, Roth TL, Sweatt JD. Epigenetic regulation of BDNF gene transcription in the consolidation of fear memory. J Neurosci 2008;28:10576–10586.
21. Karpova NN, Pickenhagen A, Lindholm J et al. Fear erasure in mice requires synergy between antidepressant drugs and extinction training. Science 2011;334:1731–1734.
22. Dell'osso L, Carmassi C, Del Debbio A et al. Brain-derived neurotrophic factor plasma levels in patients suffering from post-traumatic stress disorder. Prog Neuropsychopharmacol Biol Psychiatry 2009;33:899–902.
23. Berger W, Mehra A, Lenoci M et al. Serum brain-derived neurotrophic factor predicts responses to escitalopram in chronic posttraumatic stress disorder. Prog Neuropsychopharmacol Biol Psychiatry 2010;34:1279–1284.
24. Blake DD, Weathers FW, Nagy LM et al. The development of a clinician-administered PTSD scale. J Trauma Stress 1995;8:75–90.
25. Weathers FW, Keane TM, Davidson JR. Clinician-administered PTSD scale: a review of the first ten years of research. Depress Anxiety 2001;13:132–156.
26. Weathers FW, Ruscio AM, Keane TM. Psychometric properties of nine scoring rules for the Clinician-Administered PTSD Scale (CAPS). Psychol Assess 1999;11:124–133.
27. Keane TM, Fairbank JA, Caddell JM, Zimering RT, Taylor KL, Mora CA. Clinical evaluation of a measure to assess combat exposure. Psychol Assess 1989;1:53–55.
28. Wisco BE, Marx BP, Wolf EJ, Miller MW, Southwick SM, Pietrzak RH. Posttraumatic stress disorder in the US veteran population: results from the National Health and Resilience in Veterans Study. J Clin Psychiatry 2014;75:1338–1346.
29. Babor TF, Higgins-Biddle JC, Saunders JB, Monteiro MG. The alcohol use disorders identification test: guidelines for use in primary care. Geneva: World Health Organization, 2001.
30. Choi S, Han KM, Won E, Yoon BJ, Lee MS, Ham BJ. Association of brain-derived neurotrophic factor DNA methylation and reduced white matter integrity in the anterior corona radiata in major depression. J Affect Disord 2015;172:74–80.
31. Na KS, Won E, Kang J et al. Brain-derived neurotrophic factor promoter methylation and cortical thickness in recurrent major depressive disorder. Sci Rep 2016;6:21089.
32. Roth TL, Lubin FD, Funk AJ, Sweatt JD. Lasting epigenetic influence of early-life adversity on the BDNF gene. Biol Psychiatry 2009;65:760–769.
33. Field AP. Discovering statistics using IBM SPSS statistics, 4th edn. London: SAGE, 2013.
34. RC Team. R: a language and environment for statistical computing. Vienna, Austria: R Foundation for Statistical Computing, 2014.
35. Bredy TW, Wu H, Crego C, Zellhoefer J, Sun YE, Barad M. Histone modifications around individual BDNF gene promoters in prefrontal cortex are associated with extinction of conditioned fear. Learn Mem 2007;14:268–276.
36. Boersma GJ, Lee RS, Cordner ZA et al. Prenatal stress decreases Bdnf expression and increases methylation of Bdnf exon IV in rats. Epigenetics 2014;9:437–447.
37. Unternaehrer E, Meyer AH, Burkhardt SC et al. Childhood maternal care is associated with DNA methylation of the genes for brain-derived neurotrophic factor (BDNF) and oxytocin receptor (OXTR) in peripheral blood cells in adult men and women. Stress 2015;18:451–461.
38. Sen S, Duman R, Sanacora G. Serum brain-derived neurotrophic factor, depression, and antidepressant medications: meta-analyses and implications. Biol Psychiatry 2008;64:527–532.
39. Dwivedi Y, Rizavi HS, Pandey GN. Antidepressants reverse corticosterone-mediated decrease in brain-derived neurotrophic factor expression: differential regulation of specific exons by antidepressants and corticosterone. Neuroscience 2006;139:1017–1029.
40. Tsankova NM, Berton O, Renthal W, Kumar A, Neve RL, Nestler EJ. Sustained hippocampal chromatin regulation in a mouse model of depression and antidepressant action. Nat Neurosci 2006;9:519–525.
41. Zimmermann N, Zschocke J, Perisic T, Yu S, Holsboer F, Rein T. Antidepressants inhibit DNA methyltransferase 1 through reducing G9a levels. Biochem J 2012;448:93–102.
42. Pan W, Banks WA, Fasold MB, Bluth J, Kastin AJ. Transport of brain-derived neurotrophic factor across the blood-brain barrier. Neuropharmacology 1998;37:1553–1561.
43. Klein AB, Williamson R, Santini MA et al. Blood BDNF concentrations reflect brain-tissue BDNF levels across species. Int J Neuropsychopharmacol 2011;14:347–353.
44. Matsuoka Y, Nishi D, Noguchi H, Kim Y, Hashimoto K. Longitudinal changes in serum brain-derived neurotrophic factor in accident survivors with posttraumatic stress disorder. Neuropsychobiology 2013;68:44–50.
45. Ikegame T, Bundo M, Murata Y, Kasai K, Kato T, Iwamoto K. DNA methylation of the BDNF gene and its relevance to psychiatric disorders. J Hum Genet 2013;58:434–438.
46. Zheleznyakova GY, Cao H, Schioth HB. Bdnf, DNA methylation changes as a biomarker of psychiatric disorders: literature review and open access database analysis. Behav Brain Funct 2016;12:17.
47. Masliah E, Dumaop W, Galasko D, Desplats P. Distinctive patterns of DNA methylation associated with Parkinson disease: identification of concordant epigenetic changes in brain and peripheral blood leukocytes. Epigenetics 2013;8:1030–1038.
48. Davies MN, Volta M, Pidsley R et al. Functional annotation of the human brain methylome identifies tissue-specific epigenetic variation across brain and blood. Genome Biol 2012;13:R43.
49. Beery AK, McEwen LM, Macisaac JL, Francis DD, Kobor MS. Natural variation in maternal care and cross-tissue patterns of oxytocin receptor gene methylation in rats. Horm Behav 2016;77:42–52.
50. Huang YT, Chu S, Loucks EB et al. Epigenome-wide profiling of DNA methylation in paired samples of adipose tissue and blood. Epigenetics 2016;11:227–236.
51. Heberlein A, Buscher P, Schuster R et al. Do changes in the BDNF promoter methylation indicate the risk of alcohol relapse? Eur Neuropsychopharmacol 2015;25:1892–1897.
52. Jacobsen LK, Southwick SM, Kosten TR. Substance use disorders in patients with posttraumatic stress disorder: a review of the literature. Am J Psychiatry 2001;158:1184–1190.
53. Norman SB, Myers US, Wilkins KC et al. Review of biological mechanisms and pharmacological treatments of comorbid PTSD and substance use disorder. Neuropharmacology 2012;62:542–551.
54. McLean CP, Su YJ, Foa EB. Posttraumatic stress disorder and alcohol dependence: does order of onset make a difference? J Anxiety Disord 2014;28:894–901.